Your browser doesn't support javascript.
loading
Transformation of Polycythemia Vera to Pure Erythroid Leukemia.
Liu, Louisa; Dudheker, Neil; Sumarriva Lezama, Lhara M; Shah, Sameer; Nwaokoro, Maureen; Ranpura, Vishal.
Affiliation
  • Liu L; Internal Medicine, University of California, Riverside, Riverside, USA.
  • Dudheker N; Hematology and Oncology, University of California San Diego, San Diego, USA.
  • Sumarriva Lezama LM; Pathology, Kaiser Permanente, Los Angeles, USA.
  • Shah S; Hematology and Oncology, University of California Riverside, Riverside, USA.
  • Nwaokoro M; Internal Medicine, University of California Riverside, Riverside, USA.
  • Ranpura V; Hematology and Oncology, Kaiser Permanente, Riverside, USA.
Cureus ; 13(7): e16168, 2021 Jul.
Article in En | MEDLINE | ID: mdl-34367778
Pure erythroid leukemia (PEL) is an aggressive and exceedingly rare form of acute leukemia characterized as a neoplastic proliferation of immature cells committed to the erythroid lineage. It has a poor overall median survival of two to three months. To our knowledge, there are currently only a handful of reports of PEL arising from polycythemia vera. Most reported cases have been associated with radiation therapy or chemotherapeutic alkylating agents. Here we report a rare occurrence of polycythemia vera treated with phlebotomy and hydroxyurea that underwent leukemic transformation to pure erythroid leukemia.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States